6 Patents
- 0 cites
- US124417972025Anti-fc Ε-r1 Α (fcϵr1α) Antibodies, Bispecific Antigen-binding Molecules That Bind Fcϵr1α and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US124213172025Polynucleotides Encoding Anti-glucagon-like Peptide 1 Receptor (GLP1R) Antagonist Antibodies
Regeneron Pharmaceuticals, Inc.
0 cites - US118847362024Antibodies Which Bind to Glucagon-like Peptide 1 Receptor (GLP1R)
Regeneron Pharmaceuticals, Inc.
0 cites - US116423902023Method of Treatment with a Fusion Protein Comprising Apelin and an Anti-aplnr Antibody
Regeneran Pharmaceuticals, Inc.
0 cites - US115781272023Anti-fc Epsilon-r1 Alpha (fcεr1α) Antibodies, Bispecific Antigen-binding Molecules That Bind Fcεr1α and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites